HPGC Renmintongtai Pharmaceutical Corp (600829) — Cash Flow Quality Index
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Cash Flow Quality Index of -4.77x as of September 2025. Operating cash flow of CN¥-187.38 Million is below net income of CN¥39.30 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore HPGC Renmintongtai Pharmaceutical Corp balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HPGC Renmintongtai Pharmaceutical Corp Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for HPGC Renmintongtai Pharmaceutical Corp across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600829 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Year-by-year earnings quality comparison for HPGC Renmintongtai Pharmaceutical Corp. For live market cap and the full company financial profile, see 600829 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.24x | CN¥299.98 Million | CN¥133.84 Million | ▲ +314.1% |
| 2024 | 0.54x | CN¥115.44 Million | CN¥213.27 Million | ▼ -52.5% |
| 2023 | 1.14x | CN¥332.99 Million | CN¥292.16 Million | ▼ -2.3% |
| 2022 | 1.17x | CN¥307.33 Million | CN¥263.41 Million | ▲ +238.5% |
| 2021 | -0.84x | CN¥-233.00 Million | CN¥276.51 Million | ▼ -1224.5% |
| 2020 | -0.06x | CN¥-9.22 Million | CN¥144.96 Million | ▲ +95.9% |
| 2019 | -1.54x | CN¥-411.60 Million | CN¥267.30 Million | ▼ -208.4% |
| 2018 | 1.42x | CN¥366.45 Million | CN¥257.85 Million | ▲ +159.8% |
| 2017 | 0.55x | CN¥139.07 Million | CN¥254.20 Million | ▲ +167.0% |
| 2016 | 0.20x | CN¥46.01 Million | CN¥224.51 Million | ▼ -91.9% |
| 2015 | 2.52x | CN¥333.99 Million | CN¥132.54 Million | ▼ -83.2% |
| 2014 | 14.97x | CN¥392.58 Million | CN¥26.23 Million | ▲ +2287.9% |
| 2012 | 0.63x | CN¥221.57 Million | CN¥353.49 Million | ▲ +324.8% |
| 2011 | -0.28x | CN¥-108.30 Million | CN¥388.48 Million | ▼ -158.0% |
| 2010 | 0.48x | CN¥162.99 Million | CN¥339.38 Million | ▼ -68.5% |
| 2009 | 1.53x | CN¥447.82 Million | CN¥293.52 Million | ▲ +749.5% |
| 2008 | -0.23x | CN¥-65.93 Million | CN¥280.68 Million | ▼ -133.4% |
| 2007 | 0.70x | CN¥191.10 Million | CN¥271.83 Million | ▼ -20.8% |
| 2006 | 0.89x | CN¥191.13 Million | CN¥215.32 Million | ▼ -43.3% |
| 2005 | 1.57x | CN¥313.04 Million | CN¥199.80 Million | ▲ +4.8% |
| 2004 | 1.50x | CN¥60.69 Million | CN¥40.59 Million | ▼ -62.9% |
| 2003 | 4.03x | CN¥71.65 Million | CN¥17.79 Million | ▼ -68.1% |
| 2002 | 12.61x | CN¥127.49 Million | CN¥10.11 Million | ▲ +3668.1% |
| 2001 | 0.33x | CN¥14.79 Million | CN¥44.21 Million | ▼ -66.7% |
| 2000 | 1.01x | CN¥61.85 Million | CN¥61.54 Million | ▼ -96.0% |
| 1999 | 25.06x | CN¥58.21 Million | CN¥2.32 Million | ▼ -52.3% |
| 1998 | 52.50x | CN¥41.00 Million | CN¥780.86K | — |